Report
Community-based researchNew Drug Trends
New Drug Trends: Insights from Focus Group Discussions. Civil Society Monitoring of Harm Reduction in Europe 2025
Multiple authors 
19.02.2026
We inform, support, share & act.
We are a leading European civil society network at the intersection of drug policy, harm reduction, and social inclusion, combining research, advocacy, and practice to drive change across Europe.
Multiple authors
Opioid Agonist Maintenance Treatment/Therapy (OAMT) is an evidence-based approach to treat opioid dependence. The treatment involves taking opioid agonist medications (such as methadone or buprenorphine), which prevent withdrawal symptoms and reduce opioid cravings. Additionally, OAMT has a positive impact on our society overall by… Reducing healthcare costs as a result of lower consumption of drugs […]
Correlation – European Harm Reduction Network (C-EHRN) expresses its strong support for the initiative led by France to reinstate operating grants for health NGOs under the EU4Health Programme from 2026 onwards, and calls on Member States and the European Commission to endorse this position. Operating grants are a vital mechanism that sustain the core operational capacity of civil […]
Multiple authors
